Gong 2011.
Study characteristics | ||
Methods | Study design: randomized controlled, parallel‐group trial Setting/country: Outpatient/Department of Urology, The affiliated hospital of Chuanbei Medical University, Nanchong, China Dates study conducted: NR |
|
Participants | Inclusion criteria:
Exclusion criteria:
Number of participants randomized: 80 Group 1 (paroxetine):
Group 2 (placebo):
|
|
Interventions | Group 1: paroxetine 20 mg daily orally Group 2: oral soda tablets as a placebo |
|
Outcomes | Primary outcomes:
Safety outcomes:
|
|
Funding sources | NR | |
Declarations of interest | NR | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Methods not described. |
Allocation concealment (selection bias) | Unclear risk | Methods not described. |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Not explicitly stated whether personnel were blinded; participants appeared to be blinded. |
Blinding of outcome assessment (detection bias) Participant‐reported outcomes | Low risk | Participants likely blinded through the use of placebo. |
Blinding of outcome assessment (detection bias) Investigator‐assessed outcomes | Unclear risk | Not explicitly described. |
Blinding of outcome assessment (detection bias) IELT | Low risk | Objective measurement that was unlikely to be influenced by blinding. |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Quote: "All patients were followed up for 6 to 10 weeks." |
Selective reporting (reporting bias) | Unclear risk | No protocol available. |
Other bias | Low risk | No additional sources of bias identified. |